CoChat

The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain

Open access
Skerratt, Sarah E., Andrews, Mark, Bagal, Sharan K., Bilsland, James, Brown, David, Bungay, Peter J., Cole, Susan, Gibson, Karl R, Jones, Russell, Morao, Inaki, Nedderman, Angus, Omoto, Kiyoyuki, Robinson, Colin, Ryckmans, Thomas, Skinner, Kimberly, Stupple, Paul, Waldron, Gareth · 2016 · Journal of Medicinal Chemistry
Cited by 81

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The neurotrophin family of growth factors, comprised of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3), and neurotrophin 4 (NT4), is implicated in the physiology of chronic pain. Given the clinical efficacy of anti-NGF monoclonal antibody (mAb) therapies, there is significant interest in the development of small molecule modulators of neurotrophin activity. Neurotrophins signal through the tropomyosin related kinase (Trk) family of tyrosine kinase receptors, hence Trk kinase inhibition represents a potentially "druggable" point of intervention. To deliver the safety profile required for chronic, nonlife threatening pain indications, highly kinase-selective Trk inhibitors with minimal brain availability are sought. Herein we describe how the use of SBDD, 2D QSAR models, and matched molecular pair data in compound design enabled the delivery of the highly potent, kinase-selective, and peripherally restricted clinical candidate PF-06273340.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.6b00850

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 81

Metadata

Authors
Skerratt, S. E., Andrews, M., Bagal, S. K., Bilsland, J., Brown, D., Bungay, P. J., Cole, S., Gibson, K. R., Jones, R., Morao, I., Nedderman, A., Omoto, K., Robinson, C., Ryckmans, T., Skinner, K., Stupple, P., & Waldron, G.
Venue
Journal of Medicinal Chemistry
Published
2016-11-04
Volume
59
Issue
22
Pages
10084-10099
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2534324311
Cited by
81
References
7
Type
other
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain. https://app.cochat.ai/papers/10.1021/acs.jmedchem.6b00850
The paper
Skerratt, S. E., Andrews, M., Bagal, S. K., Bilsland, J., Brown, D., Bungay, P. J., Cole, S., Gibson, K. R., Jones, R., Morao, I., Nedderman, A., Omoto, K., Robinson, C., Ryckmans, T., Skinner, K., Stupple, P., & Waldron, G. (2016). The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6b00850

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.